Virtus ETF Advisers’s Longboard Pharmaceuticals, Inc. Common Stock LBPH Stock Holding History

Virtus ETF Advisers’s Portfolio LBPH Stock Details LBPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-4,618	Closed	-$154K	–	511
2024 Q3	$154K	Buy	4,618 +80	+2%	+$2.75K	0.07%	323
2024 Q2	$123K	Buy	+4,538	New	+$89.5K	0.06%	328

Virtus ETF Advisers's LBPH Position: Q4 2024 in Review

Virtus ETF Advisers sold out of Longboard Pharmaceuticals, Inc. Common Stock (LBPH) in Q4 2024, closing a stake of 4,618 shares — an estimated $154K sold.

Virtus ETF Advisers first reported a position in LBPH in Q2 2024 and held it in 2 quarters. The position peaked at $154K in Q3 2024. 0 funds tracked by Wall St. Rank hold LBPH as of Q4 2024.

Virtus ETF Advisers reported no remaining Longboard Pharmaceuticals, Inc. Common Stock position as of Q4 2024 after selling out during the quarter.
Virtus ETF Advisers sold 4,618 Longboard Pharmaceuticals, Inc. Common Stock shares in Q4 2024, an estimated $154K.
Virtus ETF Advisers first reported a position in Longboard Pharmaceuticals, Inc. Common Stock in Q2 2024 and held it in 2 quarters.
Virtus ETF Advisers's Longboard Pharmaceuticals, Inc. Common Stock position peaked at $154K in Q3 2024.
0 funds tracked by Wall St. Rank held Longboard Pharmaceuticals, Inc. Common Stock as of Q4 2024.

Based on Virtus ETF Advisers's 13F filing for Q4 2024, filed 14 Feb 2025.